Completed
Evaluation of Individual Bioequivalence of Gabasandoz® Relative to Neurontin® in Healthy Volunteers
NCT01821235
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsy, +9 more
- Locations
-
- Drug Research Unit Ghent (D.R.U.G.) Ghent, Belgium